The NHS has today, Monday 4 January 2021, launched the rollout of the new Oxford AstraZeneca coronavirus vaccine – with patients at Oxford University Hospitals NHS Foundation Trust (OUH) the very first to get the life-saving jab. At 7.30am this morning at the Churchill Hospital in Oxford, dialysis patient Brian Pinker was vaccinated by Sam […]
The University of Oxford welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK. The Joint Committee on Vaccination and Immunisation (JCVI) will also publish its latest advice for the […]
Dr Bruno Holthof, Chief Executive of Oxford University Hospitals (OUH), has welcomed today’s announcement that the coronavirus vaccine developed by scientists at the University of Oxford has been approved for use in the UK. The UK Government today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the Oxford-AstraZeneca vaccine in […]
Action for Carers Oxfordshire has teamed up with Enrych Oxfordshire to bring you help in your own home With so many gadgets on offer it’s hard to understand how things work, especially if you’re not used to using digital devices. Now Action for Carers Oxfordshire has teamed up with Enrych Oxfordshire to bring you help […]
A special concert to say thank you and pay tribute to the achievements of the Oxford vaccine team has been recorded at the Sheldonian Theatre for a film screening in time for Christmas. © Nick Rutter The Oxford Philharmonic Orchestra has recorded a special concert, featuring a world premiere from composer John Rutter performed by […]
In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication. From 27 November 2020, the inhaled corticosteroid budesonide will be investigated as part of the UK’s national priority platform trial for Covid-19 treatments that can be taken at home. Led by the University of Oxford, […]
Kenya has joined the global efforts in search of an effective vaccine for COVID-19 with the start of a trial evaluating the ChAdOx1 nCoV-2019 Oxford coronavirus vaccine. The trial will be hosted at KEMRI at its Kilifi based KEMRI-Wellcome Trust Research Programme, a longstanding collaboration between KEMRI, the University of Oxford and the Wellcome Trust […]
Europe’s BAPS Swaminarayan Sanstha is supporting their community during the coronavirus pandemic by spreading awareness of the PRINCIPLE trial of Covid-19 treatments. Led by Oxford University researchers, the PRINCIPLE trial is working across all UK communities to evaluate if treatment administered early in the course of the Covid-19 illness can help people aged over 50 […]
Initial findings from a study looking at the longer-term impact of COVID-19 has found that a large proportion COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus. The University of Oxford scientists carrying out the C-MORE study have also detected abnormalities […]
A team of mathematical modellers and epidemiologists at Oxford University’s Nuffield Department of Medicine release the latest model of a population responding to the coronavirus epidemic. The model – OpenABM-Covid19 – provides public health decision-makers with the ability to review the potential progression and outcome of the coronavirus, including fluctuations in infected individuals, hospitalisations, intensive care unit […]